Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Coherus BioSciences, Inc. (Coherus or the Company, Nasdaq: CHRS), today announced that its first quarter 2021 financial results will be released after market close on Thursday, May 6, 2021. Starting at 4:30 p.m. ET, Coherus management team will host a conference call and webcast to discuss financial results and provide a general business update.


GlobeNewswire Inc | Apr 30, 2021 08:15AM EDT

April 30, 2021

REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or the Company, Nasdaq: CHRS), today announced that its first quarter 2021 financial results will be released after market close on Thursday, May 6, 2021. Starting at 4:30 p.m. ET, Coherus management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing first quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com.

Conference Call Information

When: Thursday, May 6, 2021 starting at 4:30 p.m. ETDial-in: (800) 446-2782 (Toll-Free U.S. and Canada) or (847) 413-3235 (International)Conference ID: 50149707Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

AboutCoherus BioSciencesCoherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients lives and to deliver significant savings to the health care system.

For additional information, please visitwww.coherus.com.

Coherus BioSciences Contact Information:Investor Contact:McDavid Stilwell, CFOCoherus BioSciences, Inc.IR@coherus.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC